Loring Wolcott & Coolidge Fiduciary Advisors’s Sage Therapeutics SAGE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$456	Hold	50	–	–	﹤0.01%	514
2025 Q1	$381	Hold	50	–	–	﹤0.01%	549
2024 Q4	$372	Hold	50	–	–	﹤0.01%	550
2024 Q3	$393	Hold	50	–	–	﹤0.01%	564
2024 Q2	$608	Hold	50	–	–	﹤0.01%	545
2024 Q1	$645	Hold	50	–	–	﹤0.01%	556
2023 Q4	$1.28K	Hold	50	–	–	﹤0.01%	540
2023 Q3	$978	Hold	50	–	–	﹤0.01%	593
2023 Q2	$2.35K	Hold	50	–	–	﹤0.01%	607
2023 Q1	$2.1K	Hold	50	–	–	﹤0.01%	573
2022 Q4	$1.91K	Hold	50	–	–	﹤0.01%	554
2022 Q3	$2K	Hold	50	–	–	﹤0.01%	585
2022 Q2	$2K	Hold	50	–	–	﹤0.01%	616
2022 Q1	$2K	Hold	50	–	–	﹤0.01%	619
2021 Q4	$2K	Hold	50	–	–	﹤0.01%	699
2021 Q3	$2K	Hold	50	–	–	﹤0.01%	716
2021 Q2	$3K	Buy	+50	New	+$3K	﹤0.01%	812
2021 Q1	–	Sell	-50	Closed	-$4K	–	620
2020 Q4	$4K	Hold	50	–	–	﹤0.01%	713
2020 Q3	$3K	Hold	50	–	–	﹤0.01%	564
2020 Q2	$2K	Hold	50	–	–	﹤0.01%	567
2020 Q1	$1K	Hold	50	–	–	﹤0.01%	636
2019 Q4	$4K	Hold	50	–	–	﹤0.01%	621
2019 Q3	$7K	Hold	50	–	–	﹤0.01%	593
2019 Q2	$9K	Hold	50	–	–	﹤0.01%	570
2019 Q1	$8K	Hold	50	–	–	﹤0.01%	572
2018 Q4	$5K	Hold	50	–	–	﹤0.01%	601
2018 Q3	$7K	Hold	50	–	–	﹤0.01%	552
2018 Q2	$8K	Hold	50	–	–	﹤0.01%	561
2018 Q1	$8K	Hold	50	–	–	﹤0.01%	597
2017 Q4	$8K	Hold	50	–	–	﹤0.01%	584
2017 Q3	$3K	Hold	50	–	–	﹤0.01%	620
2017 Q2	$4K	Buy	+50	New	+$4K	﹤0.01%	599